prophylaxis [inpr]    
HEPATITIS B VIRUS [virs]    
Liver Transplantation [topp]    
Registry [inpr]    
Study [mnob]    
Evaluate [hlca]    
Prophylactic [phsu]    
Efficacy [qlco]    
Combination [qlco]    
Ide [fish]    
Analogue [chvs]    
Methods [inpr]    
HEPATITIS B SURFACE ANTIGEN POSITIVE [lbtr]    
Patients [podg]    
CHINA [geoa]    
LIVER TRANSPLANT [topp]    
Registry [inpr]    
data base [inpr]    
January [qlco]    
2000s [tmco]    
December [qlco]    
Low dose [qnco]    
INTRAMUSCULAR [ftcn]    
Combined [qlco]    
Ide [fish]    
Analogue [chvs]    
Very [qlco]    
Cost Effectiveness [qnco]    
Reports [inpr]    
HEPATITIS B VIRUS [virs]    
Prophylactic [phsu]    
Compared [acty]    
Based [ftcn]    
Prophylactic [phsu]    
Protocols [inpr]    
Group A [clas]    
INTRAMUSCULAR [ftcn]    
Plus [ftcn]    
Group [idcn]    
INTRAMUSCULAR [ftcn]    
Plus [ftcn]    
Group C [clas]    
INTRAMUSCULAR [ftcn]    
Plus [ftcn]    
Compared [acty]    
Related [qlco]    
baseline [bodm]    
Characteristics [qlco]    
Groups [idcn]    
Including [ftcn]    
MALE SEX [orga]    
MELD score [clna]    
TIME [tmco]    
Transplantation [topp]    
Child-Pugh Score [inpr]    
TIME [tmco]    
Transplantation [topp]    
HCC [neop]    
Pre [tmco]    
Transplantation [topp]    
HEPATITIS B E ANTIGEN [imft]    
Pre [tmco]    
Transplantation [topp]    
TIME [tmco]    
Transplantation [topp]    
Pre-Therapy [tmco]    
Transplantation [topp]    
Antiviral [phsu]    
Duration [tmco]    
Antiviral Therapy [topp]    
Transplantation [topp]    
Patients [podg]    
Calculated [ftcn]    
YEAR [tmco]    
Survival Rates [qnco]    
Differential Groups [lbpr]    
Risk Factors [qnco]    
Multivariate Analyses [qnco]    
Duration [tmco]    
MO [geoa]    
YEAR [tmco]    
Survival Rates [qnco]    
LOWER [spco]    
Group A [clas]    
Group 2 [inpr]    
YEAR [tmco]    
Significantly high [qnco]    
Group A [clas]    
Group [idcn]    
1-7 [gngm]    
3 5 [qnco]    
Exist [cnce]    
Groups [idcn]    
Groups [idcn]    
YEAR [tmco]    
HEPATOCELLULAR CARCINOMA [neop]    
Viral Load [fndg]    
Prophylactic [phsu]    
Protocol [inpr]    
Low dose [qnco]    
INTRAMUSCULAR [ftcn]    
Combination [qlco]    
Ide [fish]    
Analogue [chvs]    
effective [qlco]    
prophylaxis [inpr]    
Plus [ftcn]    
